Geode Capital Management
BCRX icon

Geode Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$45.3M Buy
5,054,610
+93,973
+2% +$842K ﹤0.01% 1478
2025
Q1
$37.2M Buy
4,960,637
+136,902
+3% +$1.03M ﹤0.01% 1550
2024
Q4
$36.3M Sell
4,823,735
-14,250
-0.3% -$107K ﹤0.01% 1633
2024
Q3
$36.8M Buy
4,837,985
+127,708
+3% +$971K ﹤0.01% 1623
2024
Q2
$29.1M Buy
4,710,277
+310,006
+7% +$1.92M ﹤0.01% 1717
2024
Q1
$22.4M Buy
4,400,271
+139,633
+3% +$709K ﹤0.01% 1863
2023
Q4
$25.5M Buy
4,260,638
+349,561
+9% +$2.09M ﹤0.01% 1769
2023
Q3
$27.7M Buy
3,911,077
+78,522
+2% +$556K ﹤0.01% 1616
2023
Q2
$27M Buy
3,832,555
+178,999
+5% +$1.26M ﹤0.01% 1660
2023
Q1
$30.5M Buy
3,653,556
+187,006
+5% +$1.56M ﹤0.01% 1524
2022
Q4
$39.8M Buy
3,466,550
+100,706
+3% +$1.16M 0.01% 1311
2022
Q3
$42.4M Buy
3,365,844
+83,687
+3% +$1.05M 0.01% 1198
2022
Q2
$34.7M Buy
3,282,157
+179
+0% +$1.89K 0.01% 1364
2022
Q1
$53.4M Buy
3,281,978
+63,502
+2% +$1.03M 0.01% 1211
2021
Q4
$44.6M Buy
3,218,476
+78,977
+3% +$1.09M 0.01% 1387
2021
Q3
$45.1M Buy
3,139,499
+26,937
+0.9% +$387K 0.01% 1369
2021
Q2
$49.2M Buy
3,112,562
+122,039
+4% +$1.93M 0.01% 1322
2021
Q1
$30.4M Buy
2,990,523
+334,394
+13% +$3.4M ﹤0.01% 1595
2020
Q4
$19.8M Buy
2,656,129
+212,417
+9% +$1.58M ﹤0.01% 1725
2020
Q3
$8.39M Buy
2,443,712
+232,959
+11% +$800K ﹤0.01% 2060
2020
Q2
$10.5M Buy
2,210,753
+7,075
+0.3% +$33.7K ﹤0.01% 1901
2020
Q1
$4.41M Buy
2,203,678
+293,274
+15% +$586K ﹤0.01% 2220
2019
Q4
$6.59M Buy
1,910,404
+427,042
+29% +$1.47M ﹤0.01% 2287
2019
Q3
$4.25M Sell
1,483,362
-3,237
-0.2% -$9.27K ﹤0.01% 2475
2019
Q2
$5.63M Buy
1,486,599
+162,090
+12% +$614K ﹤0.01% 2312
2019
Q1
$10.8M Buy
1,324,509
+96,746
+8% +$787K ﹤0.01% 1845
2018
Q4
$9.91M Buy
1,227,763
+108,785
+10% +$878K ﹤0.01% 1795
2018
Q3
$8.54M Buy
1,118,978
+115,482
+12% +$881K ﹤0.01% 2038
2018
Q2
$5.75M Buy
1,003,496
+125,845
+14% +$721K ﹤0.01% 2248
2018
Q1
$4.19M Buy
877,651
+58,236
+7% +$278K ﹤0.01% 2355
2017
Q4
$4.02M Buy
819,415
+71,665
+10% +$352K ﹤0.01% 2326
2017
Q3
$3.92M Buy
747,750
+93,166
+14% +$488K ﹤0.01% 2354
2017
Q2
$3.64M Sell
654,584
-118,531
-15% -$659K ﹤0.01% 2366
2017
Q1
$6.49M Buy
773,115
+255,975
+49% +$2.15M ﹤0.01% 1923
2016
Q4
$3.27M Buy
517,140
+17,638
+4% +$112K ﹤0.01% 2330
2016
Q3
$2.2M Buy
499,502
+6,062
+1% +$26.7K ﹤0.01% 2505
2016
Q2
$1.4M Sell
493,440
-8,543
-2% -$24.3K ﹤0.01% 2713
2016
Q1
$1.42K Buy
501,983
+25,331
+5% +$72 ﹤0.01% 2683
2015
Q4
$4.92M Buy
476,652
+39,584
+9% +$409K ﹤0.01% 1888
2015
Q3
$4.98M Buy
437,068
+31,052
+8% +$354K ﹤0.01% 1848
2015
Q2
$6.06M Buy
406,016
+17,008
+4% +$254K ﹤0.01% 1770
2015
Q1
$3.51M Sell
389,008
-30,897
-7% -$279K ﹤0.01% 2072
2014
Q4
$5.11M Buy
419,905
+2,728
+0.7% +$33.2K ﹤0.01% 1803
2014
Q3
$4.08M Buy
417,177
+48,137
+13% +$471K ﹤0.01% 1890
2014
Q2
$4.71M Buy
369,040
+90,376
+32% +$1.15M ﹤0.01% 1826
2014
Q1
$2.95M Buy
278,664
+57,029
+26% +$603K ﹤0.01% 2109
2013
Q4
$1.68M Buy
221,635
+16,109
+8% +$122K ﹤0.01% 2405
2013
Q3
$1.5M Buy
205,526
+32,927
+19% +$240K ﹤0.01% 2347
2013
Q2
$268K Buy
+172,599
New +$268K ﹤0.01% 3129